Researchers used callers, posing as the uninsured, to call primary care offices. They got appointments if they could pay the fee. Things changed, however, if the callers tried to work out a deal by which they would pay in installments. Far fewer callers could get appointments in such cases.
Frequent shift work, particularly at night, increases type 2 diabetes risk factors, according to a study in Diabetes Care. Researchers at Brigham and Women’s Hospital in Boston looked at the impact on 270,000 people who currently work the night shift, using data from the UK Biobank.
Clinical benefits associated with new cancer therapies do not justify the high prices for the medications, and some value-based payment system is needed, according to a study published in the Journal of Oncology Practice. That’s especially true regarding incremental costs, the difference in total drug price between the novel medications and standard treatment.
A state lawmaker calls insulin prices ‘outrageous.’ PhRMA and BIO are fighting the law in court on grounds that it interferes with their patent rights.
The authors of Understanding Value-Based Healthcare provide this rationale for their book in terms of how to go about improving health care: “Government cannot do it. Payers cannot do it. Regulators cannot do it. Only the people who give care can improve it.”
The new CAR-T therapy may pass ICER cost-effectiveness muster, but can the health care system afford more drugs like it?